Search form
Search
contact us
Navigation
home
boards
Jobs
job ratings
cp wire
medtech news
pharmagather
catering
advertise
whistleblower info
pharmaceutical fraud
medical device | DME fraud
clinical lab fraud
False Claims Act
Legal Help
login/register
You are here
Home
» SHAREHOLDER ALERT: Levi & Korsinsky Announces Investigation into Possible Breaches of Fiduciary Duty by the Board of Trius Therapeutics, Inc. in Connection with the Sale of Company to Cubist Pharmaceuticals, Inc.
SHAREHOLDER ALERT: Levi & Korsinsky Announces Investigation into Possible Breaches of Fiduciary Duty by the Board of Trius Therapeutics, Inc. in Connection with the Sale of Company to Cubist Pharmaceuticals, Inc.
SHAREHOLDER ALERT: Levi & Korsinsky Announces Investigation into Possible Breaches of Fiduciary Duty by the Board of Trius Therapeutics, Inc. in Connection with the Sale of Company to Cubist Pharmaceuticals, Inc.
Submitted by
admin
on July 31, 2013 - 9:54am
Source:
Yahoo/BusinessWire
News Tags:
Cubist Pharmaceuticals
Trius Therapeutics
M&A
lawsuits
Headline:
SHAREHOLDER ALERT: Levi & Korsinsky Announces Investigation into Possible Breaches of Fiduciary Duty by the Board of Trius Therapeutics, Inc. in Connection with the Sale of Company to Cubist Pharmaceuticals, Inc.
Do Not Allow Advertisers to Use My Personal information